Top Industry Leaders in the Generic Pharmaceuticals Market
Latest Generic Pharmaceuticals Companies Update:
Teva Pharmaceutical Industries' potential acquisition of Alvogen Negotiations are underway for a potential $5 billion deal, which could further consolidate the generics market if successful.
Pharmco Acquisition of West-Ward Pharmaceuticals: This smaller acquisition reflects continued consolidation within the US generics space.
Dr. Reddy's Laboratories Launched generic versions of two major drugs in the US, boosting their market share and revenue.
Sun Pharma Announced plans to invest in biosimilars and specialty generics, diversifying their product portfolio.
Lupin Received FDA approval for several new generic drugs, strengthening their presence in the US market.
List of Generic Pharmaceuticals Key companies in the market
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- LUPIN
- AbbVie Inc. (Allergan)
- AstraZeneca
- Sawai Pharmaceutical Co.Ltd.
- Hikma Pharmaceuticals PLC
- Reddy’s Laboratories Ltd.
- Cipla Inc.
- Sanofi
- Aurobindo Pharma
- Endo International plc